Victoria J. Cook

Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults

Dick Menzies, Mênonli Adjobimey, Rovina Ruslami et al. · New England Journal of Medicine · 2018 · 386 citations · Full text

Public Health, Pharmacotherapy, Antimicrobial Pharmacotherapy +16

Moderate Exercise Training and Natural Killer Cell Cytotoxic Activity in Breast Cancer Patients

D.C. Nieman, Victoria J. Cook, D. A. Henson et al. · International Journal of Sports Medicine · 1995 · 176 citations

Medicine, Immunology, Oncology +12

Transmission Network Analysis in Tuberculosis Contact Investigations

Victoria J. Cook, Sumi Sun, J Tapia et al. · The Journal of Infectious Diseases · 2007 · 86 citations · Full text

Public Health, Infectious Disease Control, Infectious Diseases +17

Genetic Variations of <i>NAT2</i> and <i>CYP2E1</i> and Isoniazid Hepatotoxicity in a Diverse Population

So Yamada, Mila Tang, Kathryn Richardson et al. · Pharmacogenomics · 2009 · 74 citations

Life Sciences, Genetics, Pharmacology +13

Adverse events in adults with latent tuberculosis infection receiving daily rifampicin or isoniazid: post-hoc safety analysis of two randomised controlled trials

Jonathon R. Campbell, Anete Trajman, Victoria J. Cook et al. · The Lancet Infectious Diseases · 2019 · 66 citations

Pharmacy, Infectious Diseases, Pharmacology +16